Navigation Links
Sosei Announces Completion of Phase III Trial for NorLevo(R)
Date:7/10/2008

Two large multinational studies, aiming to test a 12-24h regimen (Lancet, 1999) and a single administration (Lancet, 2002), both performed by the World Health Organisation (WHO) demonstrated that levonorgestrel mono therapy, such as NorLevo(R), was well-tolerated and more effective than the Yuzpe method (ethinyl estradiol and levonorgestrel), a traditional emergency contraception method used since 1977. Levonorgestrel mono therapy for emergency contraception is listed as an essential drug by the WHO.

About Sosei

Sosei Group is a leading international biopharmaceutical company with significant expertise in product discovery and development. It has established a reduced risk business model primarily upon identifying new uses for established drugs and exploiting its unique position within Japanese, European and North American pharmaceutical markets by acquiring compounds from, and bringing compounds into, Japan.

For further information about Sosei, please visit http://www.sosei.com

About HRA Pharma

HRA Pharma creates innovative medicines and products for women's and reproductive health, endocrine diseases, and cell-based therapies. The Company discovers, develops and markets its own products and licenses-in third party products as well. The company markets its products in more than 50 countries either through its own sales force or through a network of distributors and licensees.

For further information please visit the website at http://www.hra-pharma.com


'/>"/>
SOURCE Sosei Group Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
2. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
3. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
4. Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
5. Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntingtons Disease
6. Biopure Announces Meeting With FDA
7. BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
8. Applisonix Announces Breakthrough in Ultrasound Technology for Hair Removal - Average Hair Reduction of 38% Following Initial Treatment
9. Silence Therapeutics Announces Board Changes
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. Halozyme Therapeutics Announces That Chemophase Meets Primary Endpoint in Phase I/IIa Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... -- Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ) has ... Testing Market - Forecasts to 2019: Expected to ... is expected to be valued at USD 4,943.0 ... http://photos.prnewswire.com/prnh/20130307/600769 The ... according to immunoprotein types which include immunoglobulins, complement ...
(Date:7/11/2014)... DIEGO , July 11, 2014 Neurelis, ... Corp. ("Biotie") to end the option held by Biotie ... commence further development of NRL-1 (intranasal diazepam) for pediatric ... Over the past year, Biotie has advanced ... in preparation for the pivotal clinical work required for ...
(Date:7/10/2014)... -- The U.S. Department of Health and Human Services (HHS) ... Case Medical Center Seidman Cancer Center totaling $4.7 million ... care for patients with complex cancer. ... unique model developed at UH to enhance care for ... demonstrated need for high health care utilization.  ...
Breaking Medicine Technology:Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4
... indicate early non-responders unlikely to subsequently,respond, have ... earlier change in treatment strategy, COLORADO SPRINGS, ... presented at the 2007 International Congress on,Schizophrenia ... assessed earlier than is presently thought, and,challenge ...
... Time Reduced By an Average of More ... PARK, N.C., April 02, 2007 /PRNewswire/ --,Adding ... XL 24-Hour(TM) Extended-Release Tablets to,Parkinson's patients' existing ... patients to continue,their daily activities for a ...
Cached Medicine Technology:New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 2New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 3New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 4New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 5New Data Show Early Non-Response to Antipsychotic Treatment May Be,Strong Predictor of Subsequent Non-Response for People with,Schizophrenia 6Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 2Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 3Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 4Once Daily, Extended-Release Ropinirole Improves Parkinson's,Symptoms in Patients not Optimally Controlled With Levodopa 5
(Date:7/11/2014)... July 11, 2014 Recently, Fadhits.com, the distinguished ... of kids prom dresses . To bring more benefits ... has also launched a special offer for these brand new ... 2014. , The company’s sales manager says gladly, “We are ... special offer is to acknowledge all new and old customers ...
(Date:7/11/2014)... prescribed exercise as medicine, according to a QUT ... is essential to reducing the risk of death ... QUT,s Institute of Health and Biomedical Innovation, said ... and mental health, health professionals should be prescribing ... Anderson and QUT,s Dr Charlotte Seib co-authored a ...
(Date:7/11/2014)... that people who have grown up on a farm ... urban counterparts to develop the most common inflammatory bowel ... have recently been published in the European Journal ... we can now see that not only allergic diseases, ... on the environment we are exposed to early in ...
(Date:7/11/2014)... Emily Johnson, owner of the Portland Fit Body Boot ... camp has held two charity workout events and is about ... from 7:15 - 8:30 at Col Summers City Park, SE 20th ... session raised $510 for Medical Teams International. Their second workout event ... Dream. On July 26th, Johnson and Portland Fit Body Boot ...
(Date:7/11/2014)... Recently, iFitDress.com, a leading online supplier of wedding ... new collection of evening dresses for 2014. ... all these beautiful items are provided with big discounts, ... offer is July 22. , According to the ... to customer satisfaction. On the company’s website, sincere customer ...
Breaking Medicine News(10 mins):Health News:Promotion for Kids Prom Dresses Now Provided at Fadhits.com 2Health News:Exercise is the best medicine: QUT study 2Health News:Growing up on a livestock farm halves the risk of inflammatory bowel diseases 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 2Health News:Portland Fit Body Boot Camp Invites Public to Fitness Boot Camp Session Benefiting Children’s Cancer Association 3Health News:Worldwide Chic Ladies Can Buy Cheap Evening Dresses at iFitDress.com 2
... , MONDAY, July 25 (HealthDay News) -- As many ... this fall, the American Lung Association urged parents to prepare ... help ease their transition back to the classroom. "While ... necessities, it is even more essential for parents of students ...
... -- People who resume smoking after hospitalization for a heart ... for good, a new Italian study confirms. The ... times more likely to die than those who stop -- ... support long-term ,smoking-cessation efforts after discharge, the researchers said. ...
... special treatment. But when a woman with a ... a medical issue becomes pregnant, she needs highly specialized ... Hospital of Rhode Island has created New England,s only ... high-risk pregnancies and their developing fetuses. A collaboration of ...
... a picture of many trees, young people will tend to say: ... likely we are to notice a single tree before seeing the ... the bigger picture is slower in older people. In a new ... researchers have found that these age-related changes are correlated with a ...
... , MONDAY, July 25 (HealthDay News) -- Many doctors ... women at average and high risk for breast and ovarian ... of compliance could result in women missing out on treatments ... researchers pointed out in a report published in the July ...
... , FRIDAY, July 22 (HealthDay News) -- If you have ... your health may be at risk. In a review ... is linked with many types of poorer health outcomes and ... surprises here," said study author Nancy Berkman, senior health policy ...
Cached Medicine News:Health News:Preparation Key When Kids With Asthma Go Back to School 2Health News:Smoking After Heart Attack Raises Risk of Dying 2Health News:Women & Infants introduces integrated program for high-risk pregnancy 2Health News:Women & Infants introduces integrated program for high-risk pregnancy 3Health News:Older people find it harder to see the wood for the trees 2Health News:Many Doctors Ignore Cancer Genetic Testing Guidelines 2Health News:Low 'Health Literacy' Hazardous to Your Health 2
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
Perfect for use in the E.R. Stabilizes collateral ligament strains in seconds and allows hand and finger function. Made from 1/8" AliPlast™ PXE. Can be scissor trimmed....
... Slip on, warm with a ... to fit. Splint hardens as ... and reposition. Unique fiberglass knit ... polymer Straps included. Tape, 1" ...
... The Blue Line ThumStay offers thumb and ... with soft, breathable foam. Lightweight stays provide ... and can easily be contoured for proper ... with deQuervain's tenosynovitis, tendinitis, CMC joint arthritis, ...
Medicine Products: